Drug Type Fusion protein |
Synonyms E-301, E-302, E-303 + [7] |
Target |
Mechanism HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators), SIGLEC1 modulators(sialic acid binding Ig like lectin 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - |